ICD-10 · PDGM grouping

C7B-C7B — Secondary neuroendocrine tumors

Every ICD-10-CM code in this range and the PDGM clinical group CMS assigns to it, read from the CMS grouper crosswalk v07.1.26.

OASIS-E2 v1.00.0 · ingested 2026-04-26

Codes in range

8

No clinical group

1

A period cannot be grouped from these.

Barred as primary

0

CMS rejects these in the primary position.

Where these codes group

7 of the 8 codes in C7B-C7B group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. A further 1 are assigned no clinical group at all, which means a 30-day period cannot be grouped from them.

Every code in C7B-C7B

Descriptions are CMS’s own, abbreviated as CMS abbreviates them.

CodeDescriptionClinical groupPrimary position
C7B00Secondary carcinoid tumors, unspecified siteNoneCannot group
C7B01Secondary carcinoid tumors of distant lymph nodesKAccepted
C7B02Secondary carcinoid tumors of liverKAccepted
C7B03Secondary carcinoid tumors of boneKAccepted
C7B04Secondary carcinoid tumors of peritoneumKAccepted
C7B09Secondary carcinoid tumors of other sitesKAccepted
C7B1Secondary Merkel cell carcinomaKAccepted
C7B8Other secondary neuroendocrine tumorsKAccepted

Source: CMS HH PPS Grouper Software v07.1.26, effective 2026-04-01. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff.